Media Sources Report On Various Aspects Of Ebola Drug, Vaccine R&D

Media sources report on various issues surrounding research into Ebola vaccines and treatments.

Associated Press: U.S. officials unveil plan to test Ebola drugs (Marchione, 11/5).
CIDRAP News: FDA, industry officials vow to minimize barriers to Ebola vaccines (Roos, 11/5).
Reuters: U.S. Ebola researchers plead for access to virus samples (Steenhuysen, 11/5).
Reuters: E.U. scheme commits $350 million for research on Ebola vaccines, tests (Hirschler, 11/6).
WHO: New study sheds light on the importance of supportive care for Ebola patients (11/6).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.